ORIC
ORIC Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
4.92 / 10
Netural
Liquidity flow evaluation: 7.37/10 demonstrating robust fund flow characteristics. Optimistic overall, block, Medium, and Extra-large patterns are mitigated by pessimistic Small and Large indicators, pointing to positive flow perspective. Analyst sentiment reflects overwhelmingly bullish analyst consensus with strong conviction.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-13
InstitutionWedbush
Times predicted2
Historical Win Rate50.0%
Is money flowing into or out of ORIC?
- ORIC holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 4.92/10 (Netural).
